Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice

European Respiratory Journal

Volumn 24, Issue 1, 2004, Pages 143-149

  Seki, M ^a   Yanagihara, Kyana ^a   Higashiyama, Y ^a   Fukuda, Y ^a   Kaneko, Y ^a   Ohno, H ^a   Miyazaki, Y ^a   Hirakata, Y ^a   Tomono, K ^a   Kadota, J ^a   Tashiro, T ^a   Kohno, S ^a,b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cyclooxygenase 2; Cytokine; Influenza virus; Mitogen activated protein kinase; Streptococcus pneumoniae; Toll like receptors

Indexed keywords

CHEMOKINE; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOPROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL PNEUMONIA; BRONCHOPNEUMONIA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; HELPER CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLUENZA VIRUS; INOCULATION; LUNG HEMORRHAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; VIRUS LOAD; VIRUS PNEUMONIA;

ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; POLYMERASE CHAIN REACTION; PROBABILITY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 3543124246     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00126103     Document Type: Article

References (22)

1. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Crit Care Med 2001; 63: 1730-1754.
2. Glezen WP. Serious morbidity and mortality associated with influenza virus epidemics. Epidemiol Rev 1982; 4: 25-44.
3. Schwarzmann SW, Adler JL, Sullivan RL, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch Intern Med 1971; 127: 1037-1041.
4. Seemungal TR, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618-1623.
5. Reid AH, Fanning TG, Hultin JV, Taubenberger JK. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc Natl Acad Sci USA 1999; 96: 1651-1656.
6. Taubenberger JK. Influenza virus hemagglutinin cleavage into HA1, HA2: no laughing matter. Proc Natl Acad Sci USA 1998; 95: 9713-9715.
7. Taubenberger JK, Reid AH, Krafft AE, Bijwaard KE, Fanning TG. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 1997; 275: 1793-1796.
8. LeVine AM, Koeningsknecht V, Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods 2001; 94: 173-186.
9. Engelich G, White M, Hartshorn KL. Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst. J Leukoc Biol 2001; 69: 50-56.
10. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and role of platelet-activating factor receptor. J Inf Dis 2002; 186: 341-350.
11. Hayden FG, Fritz RS, Lobo MC, Alvord WG, Strober W, Straus SE. Local and systemic cytokine responses during experimental human influenza S virus infection. Relation to symptom formation and host defense. J Clin Invest 1998; 101: 643-649.
12. Otsu Y, Yanagihara K, Fukuda Y, et al. In vivo efficacy of a new quinolone, DQ-113, against Streptococcus pneumoniae in a mouse model. Antimicrob Agents Chemother 2003; 47: 3699-3703.
13. Yanagibara K, Seki M, Cheng P-W. Lipopolysaccharide induces mucus cell metaplasia in mouse lung. Am J Respir Cell Mol Biol 2001; 24: 66-73.
14. 2 production in response to pro-inflammatory signals. Eur J Immunol 1999; 29: 3793-3803.
15. Yanagihara K, Tomono K, Kuroki M, et al. Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa. Clin Exp Immunol 2000; 122: 67-71.
16. El Ahmer OR, Raza MW, Ogilvie MM, Weir DM, Blackwell CC. Binding of bacteria to HEp-2 cells infected with influenza A virus. FEMS Immunol Med Microbiol 1999; 23: 331-341.
17. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunol 2001; 2: 675-680.
18. Pleschka S, Wolff T, Ehrhardt C, et al. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nature Cell Biol 2001; 3: 301-305.
19. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1-5.
20. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271: 33157-33160.
21. 2 on interleukin-1β-induced cyclooxygenase-2 expression in human airway smooth-muscle cells. Am J Respir Crit Care Med 2000; 162: 2272-2277.
22. Oguma T, Asano K, Shiomi T, et al. Cyclooxygenase-2 expression during allergic inflammation in guinea-pig lungs. Am J Respir Crit Care Med 2002; 165: 382-386.